DDAVP
These highlights do not include all the information needed to use DDAVP Injection® safely and effectively. See full prescribing information for DDAVP Injection. DDAVP (desmopressin acetate) injection, for intravenous or subcutaneous use Initial U.S. Approval: 1978
Approved
Approval ID
651f6fee-a2c7-431b-8d5d-58b156c72244
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Sep 28, 2022
Manufacturers
FDA
Ferring Pharmaceuticals Inc.
DUNS: 103722955
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Desmopressin Acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code55566-2200
Application NumberNDA018938
Product Classification
M
Marketing Category
C73594
G
Generic Name
Desmopressin Acetate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJuly 28, 2022
FDA Product Classification
INGREDIENTS (4)
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
CHLOROBUTANOLInactive
Code: HM4YQM8WRC
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
DESMOPRESSIN ACETATEActive
Quantity: 4 ug in 1 mL
Code: XB13HYU18U
Classification: ACTIB
Desmopressin Acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code55566-2300
Application NumberNDA018938
Product Classification
M
Marketing Category
C73594
G
Generic Name
Desmopressin Acetate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJuly 28, 2022
FDA Product Classification
INGREDIENTS (4)
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
DESMOPRESSIN ACETATEActive
Quantity: 4 ug in 1 mL
Code: XB13HYU18U
Classification: ACTIB
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
CHLOROBUTANOLInactive
Code: HM4YQM8WRC
Classification: IACT